To the editor of THE EAGLE:
Massachusetts has long been known as the life science hub. Since 2005, Nuclea Biotech-
nologies, Inc. has been working to build the synergies that exist in Boston in the Berkshires. We have been successful in establishing the clinical, computational, and educational relationships which are vital for the long-term success of the life science industry.
It is clear that the Berkshires has the potential to be another life science hub within Mass-
achusetts, as our region already provides a cost-effective workforce, an attractive quality of life, a robust network of research partnerships, and supportive civic and government partners.
Even before Mayor Daniel Bianchi assumed office, he understood the value of business development in Pittsfield. The mayor has the vision for growing our business community and we are lucky to have him as a thoughtful, intelligent partner. Over the last year, Mayor Bianchi and the Pittsfield Economic Development Auth-
ority (PEDA) have worked diligently to create a blueprint for a Berkshire Innovation Center (BIC) with the Massachusetts Life Sciences Center (MLSC). Nuclea has been a major proponent of this investment to bolster our local economy and was glad to participate in the development of this proposal. Nuc-
lea has experienced significant growth and has successfully transitioned from the develop-
ment stage to commercialization. Given the ambitious goals and responsibilities that Nuclea faces, Nuclea unfortunately cannot be a direct participant in the BIC proposal.
Yet it is my sincere hope that the MLSC supports the proposed BIC and that the original goal of job creation is not confused with job retention.
I will continue be a champion for life science investment in the Berkshires because of the enormous promise it holds for the future of our local economy.
PATRICK J. MURACA
The writer is the president and CEO of Nuclea Biotechnologies, Inc., which is headquartered in Pittsfield.